Saturday 17 October 2026 Export RIGL’s income statement to Excel — free account

Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $294.3 million, up 64.1% from fiscal 2024. In the quarter to June 2026, revenue fell 22.6%, EPS fell 72.1%, free cash flow fell 230.0% and total debt fell 66.6%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

45.97 1.28 −2.71%

Follow RIGL

Alert me

Market cap: $882.6M
P/E: 2.6×
Fwd P/E: 7.9×
Dividend yield: —
F-score: 6/9
Altman Z: 2.70
Beneish M: 0.78
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	7	6	6	4
ROE Full definition →		220.06%	185.94%	174.08%	126.90%
ROA Full definition →		59.33%	108.34%	107.04%	88.46%
ROIC Full definition →		712.45%	30.28%	29.03%	16.48%
Return on Tangible Assets Full definition →		93.96%	260.43%	252.00%	357.90%
Average Days of Receivables Full definition →		59.43	64.20	60.81	73.90
Free Cash Flow per Share Full definition →		3.79	4.21	4.31	0.48
Free Cash Flow Full definition →		68.34	75.66	79.27	8.82
Capital Expenditures Full definition →		0.16	—	—	(70.57)
Other line items
Cash ROIC Full definition →		24.00%	13.30%	14.12%	1.69%
Accounts Receivable Turnover Full definition →		7.37	6.30	6.55	5.77
Accounts Payable Turnover Full definition →		5.08	3.73	4.70	4.22
Inventory Turnover Full definition →		2.15	2.24	2.43	1.92
Average Days of Payables Full definition →		72.16	133.77	82.62	61.41
Days of Inventory on Hand Full definition →		249.58	214.04	214.60	219.97
Tax Rate Full definition →		0.00	2.01	1.99	2.76
Research and Development Expense of Revenue Full definition →		10.01%	11.31%	12.19%	15.78%
Selling, General and Administrative Expense of Revenue Full definition →		40.92%	39.38%	39.64%	44.16%
Share Based Compensation of Revenue Full definition →		4.27%	4.32%	4.28%	5.93%
Interest Coverage Full definition →		15.70	17.14	18.05	15.00
Operating CF/Net income Full definition →		0.60	0.21	0.22	0.25
Depreciation/Fixed assets Full definition →		22.87	0.00	0.00	0.00
Capex/Depreciation Full definition →		0.13	0.00	0.00	(40.70)
Revenue per Share Full definition →		15.64	16.36	16.28	14.93
Operating CF per Share Full definition →		3.78	4.21	4.31	4.28
Capex per Share Full definition →		0.01	0.00	0.00	(3.81)
Capex to Sales Full definition →		0.00	0.00	0.00	0.26

Show all line items

Columns are period end dates

Stockrow Weekly